50
Participants
Start Date
August 31, 2007
Primary Completion Date
March 31, 2008
Study Completion Date
October 31, 2009
CAT-8015
The dose level of the initial cohort will be 5 μg/kg so cohorts will be dosed at 5, 10, 20, 30, 40, 50, 60…μg/kg until toxicity supervenes.
NCI, National Institutes of Health, Bethesda
Tower Hematology Oncology Medical Group, Beverly Hills
Kalinika Hemotologii Uniwersytetu Medycznego, Lodz
Lead Sponsor
MedImmune LLC
INDUSTRY